Coreceptor usage of sequential isolates from cynomolgus monkeys experimentally infected with simian immunodeficiency virus (SIVsm)

Virology

Volumn 291, Issue 1, 2001, Pages 12-21

  Vödrös, Dalma ^a,b,c   Thorstensson, Rigmor ^d   Biberfeld, Gunnel ^d   Schols, Dominique ^e   De Clercq, Erik ^d   Fenyö, Eva Maria ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c NATIONAL CENTER FOR EPIDEMIOLOGY   (Hungary)

^d SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^e REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

BOB; Bonzo; Coreceptor usage; Early SIV replication; GHOST(3) indicator cells; Immunodeficiency in macaques

Indexed keywords

CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; GREEN FLUORESCENT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL LINE; CONTROLLED STUDY; EXPERIMENTAL INFECTION; FLOW CYTOMETRY; FLUORESCENCE; GENE ACTIVATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; LONG TERMINAL REPEAT; MONKEY; NONHUMAN; OSTEOSARCOMA CELL; PRIORITY JOURNAL; QUANTITATIVE ASSAY; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS INFECTION; VIRUS REPLICATION;

CERCOCEBUS TORQUATUS ATYS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 2; MACACA; MACACA FASCICULARIS; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 0035814495     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2001.1164     Document Type: Article

References (57)

1. Co-receptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype
2. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes
3. Extensive envelope heterogeneity of simian immunodeficiency virus in tissues from infected macaques
4. Neutralization profiles of primary human immunodeficiency virus type 1 isolates in the context of coreceptor usage
5. Human immunodeficiency virus type 1 coreceptors participate in postentry stages in the virus replication cycle and function in simian immunodeficiency virus infection
6. Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry
7. RANTES, IFN-γ, CCR1, and CCR5 mRNA expression in peripheral blood, lymph node, and bronchoalveolar lavage mononuclear cells during primary simian immunodeficiency virus infection of macaques
8. The orphan seven-transmembrane receptor apj supports the entry of primary T-cell-line-tropic and dualtropic human immunodeficiency virus type 1
9. Expression cloning of new receptors used by simian and human immunodeficiency viruses
10. Identification of a major co-receptor for primary isolates of HIV-1
11. HIV-1 entry into CD4(+) cells is mediated by the chemokine receptor CC-CKR-5
12. Differential utilization of CCR5 by macrophage and T cell tropic simain immunodeficiency virus strains
13. Use of GPR1, GPR15, and STRL33 as coreceptors by diverse human immunodeficiency virus type 1 and simian immunodeficiency virus envelope proteins
14. An orphan seven-transmembrane domain receptor expressed widely in the brain functions as a coreceptor for human immunodeficiency virus type 1 and simian immunodeficiency virus
15. A novel putative G protein-coupled receptor highly expressed in lung and testis
16. Two orphan seven-transmembrane segment receptors which are expressed in CD4-positive cells support simian immunodeficiency virus infection
17. HIV-1 entry cofactor - Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor
18. Isolation of a T-lymphotropic retrovirus from naturally infected sooty mangabey monkeys (Cercocebus atys)
19. SIV adaptation to human cells
20. Molecular characterization of SIV in tissues from experimentally infected macaques
21. Simian immunodeficiency virus infection of macaques: End-stage disease is characterized by widespread distribution of proviral DNA in tissues
22. HIV type I envelope determinants for use of the CCR2b, CCR3, STRL33, and APJ coreceptors
23. Genetic variation of simian immunodeficiency viruses in nonhuman primates
24. Coreceptor specificity of temporal variants of simian immunodeficiency virus Mne
25. Analysis of simian immunodeficiency virus sequence variation in tissues of rhesus macaques with simian AIDS
26. The extent of early viral replication is a critical determinant of the natural history of simian immunodeficiency virus infection
27. Utilization of C-C chemokine receptor 5 by the envelope glycoproteins of a pathogenic simian immunodeficiency virus, SIVmac239
28. A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo
29. An early expansion of CD8αβ T cells, but depletion of resident CD8αα T cells, occurs in the intestinal epithelium during primary simian immunodeficiency virus infection
30. Intestinal intraepithelial lymphocytes are primed for gamma interferon and MIP-1beta expression and display antiviral cytotoxic activity despite severe CD4(+) T-cell depletion in primary simian immunodeficiency virus infection
31. A novel G protein-coupled receptor with homology to neuropeptide and chemoattractant receptors expressed during bone development
32. Complex determinants of macrophage tropism in env of simian immunodeficiency virus
33. Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage
34. Expression of chemokine receptors CXCR4 and CCR5 in HIV-1-infected and uninfected individuals
35. Phenotypic changes in peripheral blood monocytes of cynomolgus monkees acutely infected with simian immunodeficiency virus
36. Simian immunodeficiency viruses of diverse origin can use CXCR4 as a coreceptor for entry into human cells
37. Molecular cloning and tissue distribution of cDNA encoding a novel chemoattractant-like receptor
38. Experimental infection of cynomolgus monkeys (Macaca fascicularis) with simian immunodeficiency virus (SIVsm)
39. Progression to AIDS in macaques is associated with changes in the replication, tropism, and cytopathic properties of the simian immunodeficiency virus variant population
40. Changes in the extracellular envelope glycoprotein of variants that evolve during the course of simian immunodeficiency virus SIVMne infection affect neutralizing antibody recognition, syncytium formation, and macrophage tropism but not replication, cytopathicity, or CCR-5 coreceptor recognition
41. In vivo evolution of HIV-1 coreceptor usage and sensitivity to chemokine-mediated suppression
42. The simian immunodeficiency virus mnd(GB-1) strain uses CXCR4, not CCR5, as coreceptor for entry in human cells
43. Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4
44. A putative G protein-coupled receptor, RDC1, is a novel coreceptor for human and simian immunodeficiency viruses
45. Patterns of chemokine receptor fusion cofactor utilization by human immunodeficiency virus type 1 variants from the lungs and blood
46. Gastrointestinal T lymphocytes retain high potential for cytokine responses but have severe CD4(+) T-cell depletion at all stages of simian immunodeficiency virus infection compared to peripheral lymphocytes
47. A capture enzyme immunoassay for detection of HIV-2/SIV antigen
48. Coreceptor usage of HIV-1 isolates representing different genetic subtypes obtained from pregnant Cameroonian women. European Network for in Utero Transmission of HIV-1
49. + T cell depletion and viral replication in SIV infection
50. Quantitative evaluation of HIV-1 coreceptor use in the GHOST(3) cell assay
51. Cytokine regulation of human immunodeficiency virus type 1 entry and replication in human monocytes/macrophages through modulation of CCR5 expression
52. Neutralisation serotypes of HIW-1 field isolates are not predicted by genetic subtype
53. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro
54. Selective CXCR4 antagonism by tat: Implications for in vivo expansion of coreceptor use by HIV-1
55. Will multiple coreceptors need to be targeted by inhibitors of human immunodeficiency virus type 1 entry?
56. Neutralizing antibodies to autologous SIVsm isolates in experimentally infected cynomolgus monkeys correlate to prognosis
57. + T-cell repertoires during the early simian immunodeficiency virus infection